Skip to main content
. 2003 Oct;71(10):5461–5471. doi: 10.1128/IAI.71.10.5461-5471.2003

TABLE 2.

Primers used for the mutant construction

Mutant strain Primer and primer sequence used for mutation
Amplified or deleted (Δ) region/total ORF (bp)
Name Sequence (restriction enzyme)a
CMM1701 Pive-1-1 ggctccctatttttatttctcagc
Pive-1-2 aagcttcaccatatcttgatagatcgc (HindIII) Δ481-1860/2,004
Pive-1-3 aagcttaacgtcagcgaaagtgtcacc (HindIII)
Pive-1-4 cgaaatcgtggtagctgttgacg
CMM1702 Pive-2-1 gaagatctcgatggcctaggtgtgttggg (BglII) 12-631/900
Pive-2-2 gctctagacgccattgccaccaacacagc (XbaI)
CMM1703 Pive-3-1 gaagatcttctagtgattgtgaataccagc (BglII) 456-993/1,161
Pive-3-2 gctctagaaacaactaagtagttattcacc (XbaI)
CMM1704 Pive-4-1 tggctcaggaagtaaaag 120-618/726
Pive-4-2 gctctagatgtaaatgctgccaaatc (XbaI)
CMM1705 Pive-5-1 cgacatcggtggcccaaccatg 378-1,170/1,593
Pive-5-2 gaagatctttgaaccagtaggccgccg (BamHI)
CMM1706 Pive-6-1 gctctagaccagcacgaaccattgcaac (XbaI) 382-1,205/1,485
Pive-6-2 gaagatctcgctgatccctcaagctgatc (BglII)
CMM1707 Pive-7-1 ggcttcatttcatgaagccgc
Pive-7-2 aagctttccgaatagtctcacataggg (HindIII) Δ34-384/393
Pive-7-3 aagcttcaataccagttcccaaaaacc (HindIII)
Pive-7-4 tggatgatgaatcaagttggtcc
CMM1708 Pive-8-1 atgcaatcgtaaactcacagc
Pive-8-2 aagcttggctttcatgtaatg (HindIII) Δ10-165/231
Pive-8-3 aagcttttagaaattcctgaacac (HindIII)
Pive-8-4 gctcagggcttacactttctg
CMM1709 Pive-9-1 gctctagaactagccagcaactcttcac (XbaI) 126-685/891
Pive-9-2 gaagatctacaatcgcttcatgacctga (BglII)
CMM1710 Pive-10-1 cgggatcctcgatatcgtcaactatag (BamHI)
Pive-10-2 cgggatccttttaagttcatgtgttgg (BamHI) Δ13-291/297
Pive-10-3 cgggatccgaataatgcttttgcgtg (BamHI)
Pive-10-4 tacgtcggcactggcacctg
CMM1711 Pive-11-1 gaagatctgtaaaagttggcgttatggcg (BglII) 97-710/810
Pive-11-2 gaagatcttgaacgttgtcttggcgagc (BglII)
CMM1712 Pive-12-1 gaagatctcaagaaaacaaccactctc (BglII) 106-1,197/1,410
Pive-12-2 gaagatctatctaggttctctttggc (BglII)
a

The restriction enzyme site is underlined.

HHS Vulnerability Disclosure